Edgewise Therapeutics Inc (NAS:EWTX)
$ 28.74 -0.92 (-3.1%) Market Cap: 2.72 Bil Enterprise Value: 2.32 Bil PE Ratio: 0 PB Ratio: 5.55 GF Score: 35/100

Edgewise Therapeutics Inc at Stifel Healthcare Conference Transcript

Nov 16, 2022 / 08:00PM GMT
Release Date Price: $9.98 (-4.95%)
Unidentified Participant

Thanks, everyone, for being here. Thanks, Kevin, CEO of Edgewise Therapeutics, for being here and walking through this presentation. And we can jump into short Q&A if the time allows. So take it away.

Kevin Koch
Edgewise Therapeutics, Inc. - President & CEO

Great. Thanks. Thank you for the invitation. Looking forward to the presentation and tell you about -- a little bit about Edgewise Therapeutics. Here's my disclaimers of what I'll be saying today.

So Edgewise Therapeutics is a muscle physiology platform company looking to treat rare muscle diseases with high unmet medical need. Our first, 5506, we believe can become a foundational medicine for the treatment of all muscular dystrophies.

We have a strong platform in which we invent our drugs against novel targets. We have continuing efforts to look at additional assets from internal research as well as from external business development activities. And we have one of the most seasoned executive teams in the industry that has had success in multiple different

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot